JP2019536783A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019536783A5 JP2019536783A5 JP2019528632A JP2019528632A JP2019536783A5 JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5 JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5
- Authority
- JP
- Japan
- Prior art keywords
- tyrosine
- methyl
- cancer
- composition according
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022122538A JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/365,120 US20170080093A1 (en) | 2013-10-22 | 2016-11-30 | Tyrosine Derivatives And Compositions Comprising Them |
| US15/365,120 | 2016-11-30 | ||
| PCT/US2017/063865 WO2018102506A1 (en) | 2016-11-30 | 2017-11-30 | Tyrosine derivatives and compositions comprising them |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Division JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019536783A JP2019536783A (ja) | 2019-12-19 |
| JP2019536783A5 true JP2019536783A5 (cg-RX-API-DMAC7.html) | 2021-01-14 |
Family
ID=60703174
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528632A Pending JP2019536783A (ja) | 2016-11-30 | 2017-11-30 | チロシン誘導体及びそれらを含む組成物 |
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3548086A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2019536783A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190089191A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110062633A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017368135A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019011033A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3045110A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201991305A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL266840A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019006326A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12019501186A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018102506A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743887A (zh) * | 2019-03-26 | 2020-10-09 | 深圳先进技术研究院 | α-甲基酪氨酸或其衍生物的用途 |
| CA3140042A1 (en) | 2019-05-14 | 2020-11-19 | Tyme, Inc. | Compositions and methods for treating cancer |
| BR112022008704A2 (pt) * | 2019-11-07 | 2022-07-19 | In3Bio Ltd | Métodos e composições para uso de anticorpos de fator de crescimento em combinação com inibidores direcionados para quinase não tirosina |
| IL294803A (en) * | 2020-01-17 | 2022-09-01 | Tyme Inc | Tyrosine derivatives for modulating cancer |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| WO2005072061A2 (en) * | 2004-02-02 | 2005-08-11 | Biosight Ltd. | Conjugates for cancer therapy and diagnosis |
| JP2009534381A (ja) * | 2006-04-19 | 2009-09-24 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム | 細胞画像化および治療のための組成物および方法 |
| CA2736563C (en) * | 2007-09-10 | 2016-01-26 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| ES2706070T3 (es) * | 2012-01-17 | 2019-03-27 | Tyme Inc | Terapia de combinación para el tratamiento del cáncer |
| US9585841B2 (en) * | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
-
2017
- 2017-11-30 CN CN201780074235.7A patent/CN110062633A/zh active Pending
- 2017-11-30 MX MX2019006326A patent/MX2019006326A/es unknown
- 2017-11-30 EP EP17817552.7A patent/EP3548086A1/en not_active Withdrawn
- 2017-11-30 WO PCT/US2017/063865 patent/WO2018102506A1/en not_active Ceased
- 2017-11-30 EA EA201991305A patent/EA201991305A1/ru unknown
- 2017-11-30 CA CA3045110A patent/CA3045110A1/en active Pending
- 2017-11-30 BR BR112019011033A patent/BR112019011033A2/pt not_active IP Right Cessation
- 2017-11-30 KR KR1020197018473A patent/KR20190089191A/ko not_active Ceased
- 2017-11-30 JP JP2019528632A patent/JP2019536783A/ja active Pending
- 2017-11-30 AU AU2017368135A patent/AU2017368135A1/en not_active Abandoned
-
2019
- 2019-05-23 IL IL266840A patent/IL266840A/en unknown
- 2019-05-29 PH PH12019501186A patent/PH12019501186A1/en unknown
-
2022
- 2022-08-01 JP JP2022122538A patent/JP2022153587A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019536783A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020130125A1 (ja) | 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ | |
| JP2019504100A5 (cg-RX-API-DMAC7.html) | ||
| JP2018533582A5 (cg-RX-API-DMAC7.html) | ||
| RU2014152107A (ru) | Комбинированная терапия с использованием антител к клаудину 18.2 для лечения рака | |
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| JP2006265245A5 (cg-RX-API-DMAC7.html) | ||
| RU2016127634A (ru) | Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций | |
| JP2022551652A (ja) | 線維芽細胞増殖因子受容体シグナル伝達の調節不全を伴う癌の標的処置 | |
| EP3423112A1 (en) | Hsp90 inhibitor drug conjugates | |
| CN110478487A (zh) | 一种大环内酯化合物在逆转肿瘤多药耐药增强抗肿瘤疗效方面的应用 | |
| JP2022153587A (ja) | チロシン誘導体及びそれらを含む組成物 | |
| US20220387544A1 (en) | Novel therapeutic use | |
| WO2010086964A1 (ja) | がん治療のための併用療法 | |
| CN113811298B (zh) | 用于联合治疗小细胞肺癌的喹啉衍生物 | |
| JP2009536956A (ja) | 抗癌治療法 | |
| JPWO2021113651A5 (cg-RX-API-DMAC7.html) | ||
| CN110891944B (zh) | 用于治疗癌症的化合物、组合物及其用途 | |
| KR102896612B1 (ko) | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 | |
| JPWO2020123991A5 (cg-RX-API-DMAC7.html) | ||
| AU2013233094A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP2011514356A5 (cg-RX-API-DMAC7.html) | ||
| JP2020535112A (ja) | Ｍｉｄｈ１阻害剤とｄｎａ低メチル化剤（ｈｍａ）との組合せ | |
| EP4204428A1 (en) | 5'-substituted nucleoside monophosphates, prodrugs thereof, and uses related thereto | |
| JP2009506019A (ja) | 癌治療のための組み合わせ |